Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-01-13
1987-10-20
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514580, 514586, 514596, 514597, 514584, 514592, 514595, 514523, 514378, 514357, 514406, 514261, 514311, 514307, 514411, 514365, 514372, 514426, 514408, 514471, 514472, 514444, 514447, 514397, 514374, 514438, 514399, A61K 31505, A61K 3117, A61K 3119, A61K 3140
Patent
active
047014571
ABSTRACT:
Amidinoureas are disclosed as useful for the treatment of irritable bowel syndrome.
REFERENCES:
patent: 4239768 (1980-12-01), Rasmussen
Arzneim-Forsch/Drug Res. 28 (II), Heft 8a (1978), Douglas et al., 1435-1441.
Mir Ghulam N.
Yelnosky John
Barron Alexis
Nicholson James A.
Rorer Pharmaceutical Corporation
Savitzky Martin F.
Waddell Frederick E.
LandOfFree
Amidinoureas for treating irritable bowel syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidinoureas for treating irritable bowel syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidinoureas for treating irritable bowel syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1612582